Products and Services offered by Fulgent Genetics
COVID-19 Molecular Testing
Molecular testing is capable of detecting active COVID-19 infections in the human body. Unique genetic markers of the virus can be found in RNA that only remains in the body while the virus invades and replicates itself. One of the benefits of molecular testing is its sensitivity in detecting active infection, allowing patients to receive appropriate treatment and take measures to prevent spreading the disease.
COVID Plus+ Testing
COVID-19 and influenza A/B share similar symptoms. This could make it harder for patients to receive an accurate diagnosis promptly during flu season. Our newest molecular diagnostic test for COVID-19 now also screens for influenza A and B. With just one sample, we can help providers confirm or rule out a COVID or flu infection.
COVID Antibody Testing
Standard antibody tests detect all antibodies that respond to COVID-19 without distinction. Our FDA EUA authorized test specifically measures the level of neutralizing antibodies that prevent SARS-CoV-2 infection.
About Fulgent Genetics
Fulgent Genetics molecular diagnostics laboratory is headquartered in Temple City, CA. We received FDA Emergency Use Authorization (EUA200156) in May 2020 for RT-PCR detection of SARS-CoV-2 nucleic acid, and have since processed millions of tests across the country. Fulgent has developed specialized, user-friendly platforms to accommodate diverse testing needs, such as routine on-site screening for schools, walk-up testing, mobile “pop-up” testing, and “at-home” testing solutions. Our solution includes staffing, registration, sample collection, sample processing, analytics, and shipping logistics. As an end-to-end testing provider, we have expanded our solutions to also include SARS-CoV-2 sequencing for variant detection, as well as COVID-19 vaccination scheduling and administration.